Northwest Natural Holding Company heads into the final week of September with options traders at their most defensive in a year, even as short sellers begin to trim positions.
The clearest tension this week sits in options. The put/call ratio hit 0.37 on September 22 — a 52-week high and well above its 20-day average of 0.31. At roughly one standard deviation above that mean, the move reflects a meaningful shift toward protective positioning. Call volume still dominates, but the directional drift toward puts is sharper than anything seen in the past year. That comes as the stock has slipped 3.3% over the past month to close at $47.78, underperforming close peers OGS and SWX, both of which fell harder on the week (down 3.6% and 3.8% respectively) but started from higher ground.
Short positioning tells a more ambiguous story. SI runs at 4.7% of free float — meaningful for a regulated utility, but not extreme. The week-on-week move is a 5.4% rise in shares short, though Monday's session alone saw a 6.7% single-day drop, suggesting the build and partial unwind both happened inside the same week. Cost to borrow jumped to 0.61% on September 22, up roughly 80% over the week after touching a low of 0.34% on September 21 — a narrow spread that reflects a choppy, not a directional, lending market. Availability remains very loose at 1,531%, with around 35 million shares still available to borrow. The borrow market is not stressed. The short score sits at 46.9, broadly flat over the past 10 days, which is consistent with a lack of conviction in either direction.
The Street is similarly ambivalent. The consensus rating is hold, with three hold ratings and no sells on record. Wells Fargo upgraded NWN from Underweight to Equal-Weight on August 6, with a $50 target — notable since the analyst had only initiated at Underweight three months earlier. That target now sits roughly 4.6% above the current price, offering little premium. TD Cowen initiated at Hold with a $58 target in April, and Stifel remains the sole bull with a Buy and a $58 target raised in March. On valuation, the stock trades at 15x trailing earnings and 1.26x book, with both multiples compressing modestly over the past 30 days. EV/EBITDA of 8.9x is drifting lower. The dividend score is an outstanding 98th percentile — likely the primary reason income-oriented holders continue to anchor the register. EPS surprise, however, ranks in the 8th percentile, suggesting beats are rare. The previous earnings print on August 5 was an exception: the stock rose 4.2% the next day and held a 3.3% gain over the following week.
Institutional ownership is broadly stable and concentrated. BlackRock holds 15.9% as of August 31, having trimmed from a 16.5% filing in April. Vanguard entities collectively hold around 11.6% across two separate vehicles. Goldman Sachs trimmed its position by around 92,000 shares as of June 30. Insider activity has been net negative over the past 90 days: director David Anderson has executed four separate sells totalling 6,000 shares under a 10b5-1 plan — a pre-arranged schedule, so not a discretionary signal. Offsetting this slightly, three directors made small open-market purchases in early August at around $50.77, well above where the stock trades today.
The next scheduled earnings release falls on November 4. With the options PCR at a 52-week high and the stock pressing down toward the Wells Fargo and Stifel bull-case targets from below, the framing into that print — rate case outcomes in Oregon and Washington, and whether cost relief is durable — is where the real conversation will sit.
See the live data behind this article on ORTEX.
Open NWN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
